| 價格 | ¥413 | ¥289 | ¥872 |
| 包裝 | 200mg | 100mg | 500mg |
| 最小起訂量 | 100mg |
| 發(fā)貨地 | 上海 |
| 更新日期 | 2026-08-03 |
| 中文名稱:白藜蘆醇 | 英文名稱:Resveratrol |
| CAS:501-36-0 | 品牌: TargetMol |
| 產(chǎn)地: 美國 | 保存條件: Pure form: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| 純度規(guī)格: 99.96% | 產(chǎn)品類別: 抑制劑 |
| 貨號: T006|T1558 |
| 名稱 | Resveratrol |
| 描述 | Resveratrol (SRT 501) is a polyphenolic natural product, a plant antitoxin with antioxidant and chemopreventive activities. Resveratrol has a wide range of targets including COX, SIRT, LOC, etc. Resveratrol induces autophagy and apoptosis. |
| 細胞實驗 | HAECs were treated with RSV in the presence of isobutylmethylxanthine (IBMX). The reaction was stopped by adding ice-cold 6% trichloroacetic acid and the supernatant fractions of the cellular lysates were extracted, dried and acetylated. Cyclic GMP levels were determined by an enzyme immunoassay kit and results standardized by protein levels [5]. |
| 動物實驗 | Eight-week male apoE-/- mice (C57BL/6 background) were used in the study. Mice were housed in photobiologic light-exposure chambers with a 12:12-h light:dark cycle, and eat food ad libitum. Mice were randomly divided into two groups: one group receiving a high cholesterol diet (HCD, 21% fat, 19.5% casein, and 1.5% cholesterol), the other receiving HCD supplemented with RSV (200 mg/100 g diet). All mice were fed for 8 weeks. To identify the potential role of PKA, some mice were treated with PKA specific inhibitor (KT5720, 1.2 mg/kg) via intraperitoneal injection once a day at the last 4 weeks. The animal experiments were conducted according to the institutional guidelines of Guangdong Provincial People's Hospital [5]. |
| 體外活性 | 方法:小鼠乳腺癌細胞 4T1 用 Resveratrol (50-250 μM) 處理 72 h,使用 CCK-8 檢測細胞活力。 結(jié)果:Resveratrol 劑量依賴性抑制 4T1 細胞的活力,IC50 為 93 μM。[1] 方法:人乳腺癌細胞 MCF-7 用 Resveratrol (1-100 μM) 處理 24 h,使用 luciferin-luciferase assay 檢測細胞內(nèi) ATP 含量。 結(jié)果:Resveratrol 降低了細胞 ATP 含量。在 1 μM Resveratrol 時降低了約 16%,在 100 μM Resveratrol 時降低了 50%。[2] |
| 體內(nèi)活性 | 方法:為檢測體內(nèi)抗腫瘤活性,將 Resveratrol (50-100 mg/kg,5% ethanol and 25% polyethyleneglycol 400 in distilled water) 腹腔注射給攜帶人卵巢畸胎瘤 PA-1 的 BALB/c (nu/nu) 小鼠,每天一次,持續(xù)四周。 結(jié)果:Resveratrol 抑制 PA-1 細胞異種移植物的生長,抑制 eEF1A2 的表達。[3] 方法:為研究對抑郁癥小鼠的影響,將 Resveratrol (10-30 mg/kg) 腹腔注射給抑郁癥模型的 C57BL/6 小鼠,每天一次,持續(xù)二十一天。 結(jié)果:Resveratrol 可顯著提高前額葉皮層神經(jīng)遞質(zhì) DA 和 5-HT 的水平,并增加大腦中 NPY 的表達,這對抑郁癥起到拮抗作用。[4] |
| 存儲條件 | Pure form: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| 溶解度 | DMSO : 131.3 mg/mL (575.27 mM), Sonication is recommended. 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 4.2 mg/mL (18.4 mM), Solution. H2O : < 1 mg/mL (insoluble or slightly soluble) Ethanol : < 1 mg/mL (insoluble or slightly soluble) |
| 關(guān)鍵字 | SRT-501 | SRT501 | Sirtuin | SIRT2 | SIRT1 | RNASynthesis | RNA Synthesis | Resveratrol | Quinone reductase 2 | Mitophagy | LOX | Keap1-Nrf2 | IκB | IKKβ | IKK | IkB/IKK | IkB | Fungal | DNASynthesis | DNA Synthesis | DNA polymerase α | COX-2 | COX-1 | Bacterial | Autophagy | Apoptosis | Antibiotic |
| 相關(guān)產(chǎn)品 | Hexane-1,6-diol | L-Cystine | Guanidine hydrochloride | L-Methionine | Aceglutamide | 1,4-Naphthoquinone | HEPPS | 5-Fluorouracil | Curcumin | Adenine | Thymidine | Diisononyl phthalate |
| 相關(guān)庫 | 抗癌上市藥物庫 | 抗癌活性化合物庫 | 清熱解毒中藥單體庫 | 苗藥化合物庫 | 激酶抑制劑庫 | 藥食同源庫 | 抗衰老化合物庫 | 化妝品成分化合物庫 | 煙草單體化合物庫 | FDA 上市激酶抑制劑庫 | 中藥抗炎分子庫 | 抗癌臨床化合物庫 |
| 成立日期 | 2013-04-18 (14年) | 注冊資本 | 566.2651萬人民幣 |
| 員工人數(shù) | 100-500人 | 年營業(yè)額 | ¥ 1億以上 |
| 主營行業(yè) | 化學(xué)試劑,生物活性小分子 | 經(jīng)營模式 | 貿(mào)易,試劑,定制,服務(wù) |
| 產(chǎn)品名稱 | 價格 | 公司名稱 | 報價日期 | |
|---|---|---|---|---|
| ¥700 |
VIP3年
|
河北九星化工產(chǎn)品有限公司
|
2026-08-04 | |
| 詢價 |
VIP7年
|
山西玉寧生物科技有限公司
|
2026-08-04 | |
| ¥500 |
VIP7年
|
南京擇優(yōu)新材料科技有限公司
|
2026-08-04 | |
| 詢價 |
VIP7年
|
湖北博杰生物科技有限公司
|
2026-08-04 | |
| 詢價 |
VIP6年
|
武漢鼎信通藥業(yè)有限公司
|
2026-08-04 | |
| ¥68 |
VIP1年
|
湖北恒碩化工有限公司
|
2026-08-04 | |
| 詢價 |
VIP7年
|
武漢裕清嘉衡藥業(yè)有限公司
|
2026-08-04 | |
| ¥1510 |
VIP2年
|
西安金萃坊植物技術(shù)開發(fā)有限公司
|
2026-08-04 | |
| 詢價 |
VIP5年
|
泰安市江舟生物科技有限公司
|
2026-08-04 | |
| ¥1450 |
VIP3年
|
江蘇輝潤藥業(yè)有限公司
|
2026-08-04 |